Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 10:45 PM UTC
| NCT Number | NCT07524322 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE1 |
| Target Enrollment | 63 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Regor Pharmaceuticals Inc. |
| Last Updated on CT.gov | July 22, 2026 (Jul 22, 2026) |
As of August 27, 2026: Clinical trial NCT07524322 is currently recruiting participants. This phase1 study for breast cancer is actively seeking new participants at 5 locations across the United States. The study is sponsored by Regor Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07524322 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07524322 was last updated Jul 22, 2026 (July 22, 2026). HelloStudys verifies this status automatically.